Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference18 articles.
1. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders;Paiva;Cytometry B: Clin. Cytometry,2010
2. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation;Ely;Am. J. Pathol.,2002
3. The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma;Pellat-Deceunynck;Leukemia,1998
4. Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy;Mateo;J. Clin. Oncol.,2008
5. CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis;Bataille;Leuk. Res.,2008
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM);Annals of Hematology;2023-12-05
2. Correlation between conventional karyotype, interphase fish and immunophenotype in risk stratification of newly diagnosed plasma cell myeloma: An observational study;Medical Journal Armed Forces India;2023-06
3. Immunophenotypic expression profile of multiple myeloma cases at a tertiary hospital in Nairobi Kenya;Frontiers in Medicine;2023-05-12
4. High Red Blood Cell Distribution Width to Platelet Ratio is an Independent Poor Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma;Discovery Medicine;2023
5. Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation;BMC Cancer;2022-12-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3